60
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Increased Placental Telomerase mRNA in Hypertensive Disorders of Pregnancy

, MD, , PhD , MD, , MD, , PhD, , PhD & , PhD
Pages 434-445 | Published online: 19 Jul 2010

REFERENCES

  • Levine RJ, Thadhani R, Qian C, Urinary placental growth factor and risk of preeclampsia. JAMA 2005; 293:77–85.
  • Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. Br Med J 2005; 330:565.
  • Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179:1359–1375.
  • Blasco MA, Gasser SM, Lingner J. Telomeres and telomerase. Genes Dev 1999; 13:2353–2359.
  • Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345:458–460.
  • Allsopp RC, Vaziri H, Patterson C, Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89:10114–10118.
  • Fitzpatrick AL, Kronmal RA, Gardner JP, Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 2007; 165:14–21.
  • Benetos A, Gardner JP, Zureik M, Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension 2004; 43:182–185.
  • Aviv A. Chronology versus biology: telomeres, essential hypertension, and vascular aging. Hypertension 2002; 40:229–232.
  • Jeanclos E, Krolewski A, Skurnick J, Shortened telomere length in white blood cells of patients with IDDM. Diabetes 1998; 47:482–486.
  • Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet 2001; 358:472–473.
  • Von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27:339–344.
  • Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 1995; 5:249–255.
  • Nakamura TM, Morin GB, Chapman KB, Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277:955–959.
  • Nakayama J, Tahara H, Tahara E, Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998; 18:65–68.
  • Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 1998; 58:1558–1561.
  • Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996; 18:173–179.
  • Izutsu T, Kudo T, Sato T, Telomerase activity in human chorionic villi and placenta determined by TRAP and in situ TRAP assay. Placenta 1998; 19:613–618.
  • Castellucci M, Kosanke G, Verdenelli F, Huppertz B, Kaufmann P. Villous sprouting: fundamental mechanisms of human placental development. Hum Reprod Update 2000; 6:485–494.
  • Lehner R, Bobak J, Kim NW, Shroyer AL, Shroyer KR. Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole. Obstet Gynecol 2001; 97:965–970.
  • Nishi H, Nakada T, Kyo S, Inoue M, Shay JW, Isaka K. Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol 2004; 24:6076–6083.
  • Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1–S22.
  • ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002; 99:159–167.
  • Centlow M, Carninci P, Nemeth K, Mezey E, Brownstein M, Hansson SR. Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes. Fertil Steril 2007; 90(5):1834–1843.
  • Selman L, Skjodt K, Nielsen O, Floridon C, Holmskov U, Hansen S. Expression and tissue localization of collectin placenta 1 (CL-P1, SRCL) in human tissues. Mol Immunol 2008; 45(11):3278–3288.
  • Gribble S, Andrews K, Williams D, Fluorescence in situ hybridization detection of two telomeres on the short arm of a derived chromosome 16 in an infant with thrombocytopenia. Cancer Genet Cytogenet 2000; 120:99–104.
  • Chang S, Khoo CM, Naylor ML, Maser RS, DePinho RA. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev 2003; 17:88–100.
  • Chen RJ, Chu CT, Huang SC, Chow SN, Hsieh CY. Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies. Hum Reprod 2002; 17:463–468.
  • Nelson NJ. Researchers debate clinical role of telomerase. J Natl Cancer Inst 1996; 88:1021–1023.
  • Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 1999; 103:1641–1650.
  • Rajakumar A, Conrad KP. Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. Biol Reprod 2000; 63:559–569.
  • Zhang P, Chan SL, Fu W, Mendoza M, Mattson MP. TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability. FASEB J 2003; 17:767–769.
  • Seimiya H, Tanji M, Oh-hara T, Tomida A, Naasani I, Tsuruo T. Hypoxia up-regulates telomerase activity via mitogen-activated protein kinase signaling in human solid tumor cells. Biochem Biophys Res Commun 1999; 260:365–370.
  • Smith SC, Leung TN, To KF, Baker PN. Apoptosis is a rare event in first-trimester placental tissue. Am J Obstet Gynecol 2000; 183:697–699.
  • Holt SE, Glinsky VV, Ivanova AB, Glinsky GV. Resistance to apoptosis in human cells conferred by telomerase function and telomere stability. Mol Carcinog 1999; 25:241–248.
  • Caniggia I, Mostachfi H, Winter J, Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 2000; 105:577–587.
  • Valdes AM, Andrew T, Gardner JP, Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366:662–664.
  • Bodnar AG, Ouellette M, Frolkis M, Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349–352.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.